BeStock  
Stocks › Biotechnology › JAZZ

Jazz Pharmaceuticals JAZZ

US equityMarket cap rank #1119Biotechnology
$230.26 −$6.19 (-2.62%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $230.62 +0.16%
Open$235.19
Prev close$236.45
Day range$227.95 – $238.59
Volume984.7K
Market cap$14.78B
P/E (TTM)68.1
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings68.1x
CheapRich

Near the top of its 5-year range · 88th percentile, 5-year average 60.8x

#2745 of 2996 stocks by PE (1 = cheapest)

Price / book3.5x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 2.4x

#4106 of 5338 stocks by PB (1 = cheapest)

Price / sales3.1x
CheapRich

Near the top of its 5-year range · 88th percentile, 5-year average 2.4x

#3382 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-803x318x1,438x2,559xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$238.00
Price vs. fair value-3.3%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.53 – 2.43 96% (pricier than usual) #4106 of 5338 (1 = cheapest)
PE 68.12 11.72 60.77 88% (pricier than usual) #2745 of 2996 (1 = cheapest)
PS 3.13 2.96 2.39 88% (pricier than usual) #3382 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on JAZZ.

Sign in to join the discussion.

Scroll to Top